American Health And Drug Benefits

Standardized Documentation Can Improve Diagnostic Testing Decisions for Patients with Cardiovascular Disease

Can Academic Detailing Move the Needle for Patients with Diabetes in a State-Based Prescription Drug Benefit Program?

Analysis of Real World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia

The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab

A Shift in Party Majority, a Shift in Priority? What the Pharmaceutical Industry Can Expect

Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database

Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study

Effects of Educational Messaging on Urgent and Emergent Care-Seeking Behaviors Among Publicly Insured Populations

Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States

Dipeptidyl Peptidase-4 Inhibitors and Joint Pain: A Retrospective Cohort Study of Older Veterans with Type 2 Diabetes Mellitus